Milestone Pharmaceuticals (MIST) stock

Worth $82.4MShares as of Aug 12

$0.66

-10.27%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score MIST. It is priced too low for a fair Quality Score.

Healthcare · Biotech

Next2H 2026“Previously announced plans to enroll the first patient in the second half of 2026 remain on track.”Trial start · SEC filing · Aug 12

Follow MIST's trial news. Pro members can get an alert when Milestone Pharmaceuticals files news, and see its trials, share raises, and its CEO's filings.

Get an alert when MIST files news on its trialsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

What's next for MIST, and how long its cash lasts

Next step the company has named

2H 2026“Previously announced plans to enroll the first patient in the second half of 2026 remain on track.”Trial start · SEC filing · Aug 12

What it means: when a trial begins, or reaches the stage the company named.

A trial underway: ReVeRA-301Phase 3 · Recruiting · 750 people · main data estimated Dec 2028 · NCT06716021

1 more trial, 36 filings, for Pro members.

Cash runway

The company says its cash lasts into H2 2027 (8-K, Aug 12).

That is the company's estimate. Our arithmetic on its latest balance sheet reads differently, so we show its words, not ours.

For Pro members: the cash on hand, the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed May 13, 2026)
At-the-market share sales program (S-3, filed May 13, 2026)

For Pro members: 3 raises and their amounts, and the share count against a year ago.

Insiders

CEO Joseph Oliveto sold 36,500 shares on Apr 16, under a planned sale. 6 more insider trades this year.

From Form 4: open-market buys and sales only.

Get an alert when Joseph Oliveto buys or sells

For Pro members: every trade, and Joseph Oliveto’s 11 filings and quotes.

Get an alert when MIST files news on its trialsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

MIST's latest filings

A notice about its exchange listing8-K, filed Oct 28
Quarterly report10-Q, filed Aug 12
7 insider filingsForm 4, filed Jun 12

20 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why MIST isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. MIST trades at $0.66. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.